Your browser doesn't support javascript.
loading
The differences between GluN2A and GluN2B signaling in the brain.
Sun, Yongjun; Xu, Yingge; Cheng, Xiaokun; Chen, Xi; Xie, Yinghua; Zhang, Linan; Wang, Long; Hu, Jie; Gao, Zibin.
Afiliação
  • Sun Y; Department of Pharmacy, Hebei University of Science and Technology, Shijiazhuang, People's Republic of China.
  • Xu Y; Hebei Research Center of Pharmaceutical and Chemical Engineering, Hebei University of Science and Technology, Shijiazhuang, People's Republic of China.
  • Cheng X; Department of Pharmacy, Hebei University of Science and Technology, Shijiazhuang, People's Republic of China.
  • Chen X; Department of Physical and Chemical Analysis, North China Pharmaceutical Group New Drug Research and Development Co., Ltd, Shijiazhuang, People's Republic of China.
  • Xie Y; Department of Pharmacy, Hebei University of Science and Technology, Shijiazhuang, People's Republic of China.
  • Zhang L; Department of Pharmacy, Hebei University of Science and Technology, Shijiazhuang, People's Republic of China.
  • Wang L; Hebei Research Center of Pharmaceutical and Chemical Engineering, Hebei University of Science and Technology, Shijiazhuang, People's Republic of China.
  • Hu J; Department of Pathophysiology, College of Basic Medical Science, Hebei Medical University, Shijiazhuang, People's Republic of China.
  • Gao Z; Department of Family and Consumer Sciences, California State University, Long Beach, California.
J Neurosci Res ; 96(8): 1430-1443, 2018 08.
Article em En | MEDLINE | ID: mdl-29682799
ABSTRACT
The N-methyl-d-aspartate (NMDA) receptor, a typical ionotropic glutamate receptor, is a crucial protein for maintaining brain function. GluN2A and GluN2B are the main types of NMDA receptor subunit in the adult forebrain. Studies have demonstrated that they play different roles in a number of pathophysiological processes. Although the underlying mechanism for this has not been clarified, the most fundamental reason may be the differences between the signaling pathways associated with GluN2A and GluN2B. With the aim of elucidating the reasons behind the diverse roles of these two subunits, we described the signaling differences between GluN2A and GluN2B from the aspects of C-terminus-associated molecules, effects on typical downstream signaling proteins, and metabotropic signaling. Because there are several factors interfering with the determination of subunit-specific signaling, there is still a long way to go toward clarifying the signaling differences between these two subunits. Developing better pharmacology tools, such as highly selective antagonists for triheteromeric GluN2A- and GluN2B-containing NMDA receptors, and establishing new molecular biological methods, for example, engineering photoswitchable NMDA receptors, may be useful for clarifying the signaling differences between GluN2A and GluN2B.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Encéfalo / Receptores de N-Metil-D-Aspartato Limite: Animals Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Encéfalo / Receptores de N-Metil-D-Aspartato Limite: Animals Idioma: En Ano de publicação: 2018 Tipo de documento: Article